Figures & data
Figure 1. Some important miRNAs in SARS-CoV-2 life cycle and pathogenesis
Cell Cycle
Volume 20, 2021 - Issue 2
Review
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?
, , 
, &
A. Wallace Hayesd University of South Florida, Tampa, FL, USA;e Michigan State University, East Lansing, MI, USAhttps://orcid.org/0000-0002-6316-3179View further author information
https://orcid.org/0000-0002-6316-3179View further author information, & Gholamreza Karimia Pharmaceutical Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran;g Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IranCorrespondence[email protected]
https://orcid.org/0000-0002-1273-5448View further author information
https://orcid.org/0000-0002-1273-5448View further author informationReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.